A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility

OBJECTIVES: To perform a cost-effectiveness evaluation comparing the originator follitropin alfa (Gonal-f(®)) to the biosimilar (Bemfola(®)) in the Italian and Spanish contexts, with an assessment of the German and UK backgrounds. METHODS: Starting from the study by Rettenbacher et al, a cost-effect...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Womens Health
Egile Nagusiak: Gizzo, Salvatore, Garcia-Velasco, Juan A, Heiman, Franca, Ripellino, Claudio, Bühler, Klaus
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153281/
https://ncbi.nlm.nih.gov/pubmed/27994486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S118687
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak